CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers

M H Rapaport1, C G McAllister, D Pickar

  • 1Department of Psychiatry, University of California, San Diego, USA.

Insights

Cytokine levels in cerebrospinal fluid (CSF) did not differ between schizophrenic patients and healthy controls. However, Interleukin-1 alpha (IL-1 alpha) and Interleukin-2 (IL-2) showed a significant positive correlation in all subjects.

Area of Science:

  • Neuroimmunology
  • Psychiatry
  • Cytokine Research

Background:

  • Cytokines play a role in modulating the central nervous system.
  • Immune activation is being explored for its connection to psychosis.

Purpose of the Study:

  • To investigate cerebrospinal fluid (CSF) levels of IL-1 alpha and IL-2 in medicated schizophrenic patients and normal volunteers.
  • To explore the relationship between immune activation and psychosis through cytokine measurement.

Main Methods:

  • Competitive enzyme immunoassay was used to measure CSF IL-1 alpha and IL-2.
  • Study included 60 medicated schizophrenic patients and 21 healthy volunteers.

Main Results:

  • No significant difference in mean CSF IL-1 alpha levels between patients (1.01 ng/ml) and controls (1.28 ng/ml).
  • No significant difference in mean CSF IL-2 levels between patients (0.970 ng/ml) and controls (1.25 ng/ml).
  • A significant positive correlation (r = 0.50, p = 0.0001) was found between CSF IL-1 alpha and IL-2 levels in all subjects.

Conclusions:

  • CSF IL-1 alpha and IL-2 levels do not distinguish schizophrenic patients from healthy controls.
  • A significant association exists between IL-1 alpha and IL-2 in the CSF of the studied population.